Application 214230
- Type
- ANDA
- Sponsor
- MANKIND PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SUGAMMADEX | SUGAMMADEX | INJECTABLE;INJECTION | 200MG/2ML(100MG/ML) | No | No |
| 002 | SUGAMMADEX | SUGAMMADEX | INJECTABLE;INJECTION | 500MG/5ML(100MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214230-001 | SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 | |
| A214230-002 | SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214230-001 | AP |
| A214230-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A214230-001 | SUGAMMADEX SODIUM | EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A214230-002 | SUGAMMADEX SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A214230-001 | SUGAMMADEX SODIUM | EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A214230-002 | SUGAMMADEX SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 | caaa826d4ba7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A214230-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A214230-002 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A214230-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A214230-002 | AP | 1 | caaa826d4ba7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| sugammadex | SUGAMMADEX | Medical Purchasing Solutions, LLC | 5b14e457-5ea1-3fe2-e063-6294a90aff6f | 2026-09-09 | Warnings, Adverse reactions | sugammadex SUGAMMADEX |
| sugammadex | SUGAMMADEX SODIUM | Solupharm Pharmazeutische Erzeugnisse GmbH | f92c4e53-13d1-46f2-acf8-6730c3cfac69 | 2026-08-20 | Warnings, Adverse reactions | sugammadex |
| sugammadex | SUGAMMADEX | Accord Healthcare Inc. | 57bf9b96-0550-b8e4-e063-6294a90a317b | 2026-08-05 | Warnings, Adverse reactions | sugammadex SUGAMMADEX |
| sugammadex | SUGAMMADEX | Somerset Therapeutics, LLC | 70c00636-d4ba-4939-802c-9d5a92435c93 | 2026-08-03 | Warnings, Adverse reactions | sugammadex SUGAMMADEX |
| sugammadex | SUGAMMADEX | Fresenius Kabi USA, LLC | 8e685b67-6804-4d97-b43e-0259b3fe231f | 2026-08-03 | Warnings, Adverse reactions | sugammadex SUGAMMADEX |
| Sugammadex | SUGAMMADEX | Lupin Pharmaceuticals, Inc. | 9f2e66d7-a5d2-4593-bb30-6d4a418381aa | 2026-07-31 | Warnings, Adverse reactions | Sugammadex SUGAMMADEX |
| Sugammadex | SUGAMMADEX | Hikma Pharmaceuticals USA Inc. | c8c1dccf-9be3-49b2-a5d9-46c2b9ca0193 | 2026-07-31 | Warnings, Adverse reactions | Sugammadex SUGAMMADEX |
| sugammadex | SUGAMMADEX | Gland Pharma Limited | c61ee55a-e61b-4d3c-9ebc-cbf57290e36c | 2026-07-28 | Warnings, Adverse reactions | sugammadex SUGAMMADEX |
| Sugammadex | SUGAMMADEX | B. Braun Medical Inc. | d9d4467c-97ae-462a-9722-cc8d62db3e83 | 2026-07-28 | Warnings, Adverse reactions | Sugammadex SUGAMMADEX |
| sugammadex | SUGAMMADEX | GLENMARK PHARMACEUTICALS INC., USA | e7897fc1-4553-460c-a29b-0bc91cd9ca10 | 2026-07-28 | Warnings, Adverse reactions | sugammadex SUGAMMADEX |
| Sugammadex | SUGAMMADEX | Novadoz Pharmaceuticals LLC | ab41ea1c-266f-421c-8fc4-6e7ff518a75d | 2026-07-09 | Warnings, Adverse reactions | Sugammadex SUGAMMADEX |
| sugammadex | SUGAMMADEX | Sun Pharmaceutical Industries, Inc. | 55b2eb4e-4d77-c555-e063-6294a90abf9e | 2026-07-03 | Warnings, Adverse reactions | sugammadex SUGAMMADEX |
| Sugammadex | SUGAMMADEX | Zydus Pharmaceuticals USA Inc. | 21028965-598b-4cfa-a614-5c28ed40306a | 2026-07-02 | Warnings, Adverse reactions | Sugammadex SUGAMMADEX |
| Sugammadex | SUGAMMADEX | Zydus Lifesciences Limited | b1ec2b5e-a571-4511-ab44-d4193441330a | 2026-07-02 | Sugammadex SUGAMMADEX | |
| Sugammadex | SUGAMMADEX SODIUM | Sagent Pharmaceuticals | 5b25f16e-726a-4464-88da-b188c2f4e038 | 2026-06-16 | Warnings, Adverse reactions | Sugammadex |
| Sugammadex | SUGAMMADEX | Camber Pharmaceuticals, Inc. | 9adda802-fab2-40c1-9c2f-358debdfb249 | 2026-05-30 | Warnings, Adverse reactions | Sugammadex SUGAMMADEX |
| sugammadex | SUGAMMADEX | Fosun Pharma USA Inc. | 4f1c7cf8-3db7-3f92-e063-6394a90aece9 | 2026-04-03 | Warnings, Adverse reactions | sugammadex SUGAMMADEX |
| BRIDION | SUGAMMADEX | Merck Sharp & Dohme LLC | 5171d883-fe8f-482c-97ab-40b00975b64a | 2026-03-13 | Warnings, Adverse reactions | SUGAMMADEX |
| Sugammadex | SUGAMMADEX | Dr. Reddy's Laboratories Inc. | 4f90c37e-3505-0968-38fd-fc7e4dd66e82 | 2026-02-18 | Warnings, Adverse reactions | Sugammadex SUGAMMADEX |
| Sugammadex | SUGAMMADEX | Mylan Institutional LLC | eb84def8-933b-4eba-b81f-30d40b1e3d8d | 2026-02-04 | Warnings, Adverse reactions | Sugammadex SUGAMMADEX |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 73410 | ORIG | 2024-02-14 |